Don’t be afraid of prostate cancer combination treatment to extend patients’ lives | am730

In Hong Kong, prostate cancer is the third most common cancer among men, with a chance of 1 in 23 men developing it and being the fourth deadliest cancer. However, while there is a need for regular screening, early diagnosis and prompt treatment, with today’s advanced treatment, it is not impossible to prolong the life of prostate cancer patients.

Recently, at the special health talk “Learn more about prostate cancer diagnosis and treatment!”, host Dr. Li Siu-hong, an expert in clinical oncology, pointed out that the median age for prostate cancer diagnosis in Hong Kong. year old, and men over 50 years old have a higher risk, and in the ten years from 2011 to 2021, the number of prostate cancer in Hong Kong increased by 85%.

Detect cancer cells as a gold standard

Dr. Li Siu-kang suggested diagnostic methods for early diagnosis of prostate cancer, including digital anal examination and prostate specific antigen (PSA) blood test. PSA is a tumor marker. If an abnormality is found in PSA, further studies are required, such as PSMA positron scan, magnetic resonance scan, etc.;

Prostate cancer tumors grow very slowly already in the advanced stage when they are detected, and some patients are even autopsied after death.

Of course, the treatment plan is the thing that worries patients the most, which will be determined based on several factors, including cancer stage, Gleason score, age, overall health, etc. Treatment options include surgery, radiation therapy (electrotherapy), hormonal therapy (castration), and chemotherapy (chemotherapy).

For patients with early-stage prostate cancer, surgery is the most common form of treatment that may occur after surgery, including urinary incontinence and affected sexual function. , electrotherapy can cause bleeding in the stool, and other hormonal treatments Chemotherapy also has its own risks There are different side effects, but there are methods/remedies for these side effects that can improve or make the symptoms disappear gradually over time.

A two-in-one/three-in-one treatment for mHSPC

Dr. Li Zhaokang confirmed that after the treatment is completed, the doctor will continue to monitor the patient’s PSA level. As soon as an abnormality is detected, such as a sharp increase in PSA levels or other worsening symptoms, the patient will be diagnosed with hormone-sensitive metastatic prostate cancer (mHSPC). with new oral hormonal drugs as a two-in-one treatment; or the two additional chemotherapy make a three-in-one treatment to extend the patient’s survival.

When prostate cancer cells grow resistant to traditional hormonal therapy and are determined to be castration-refractory prostate cancer (mCRPC), doctors will then use radioisotope therapy, new oral hormonal drug therapy, chemotherapy, PARP inhibitors, immunotherapy, etc. ‘ symptoms and pain, control the condition, extend life expectancy, and maintain quality of life.

According to NCCN cancer guidelines, specific gene testing can develop personalized treatment plans and improve treatment effectiveness. In life, maintaining sexual contact with your partner, exercising moderately, supplementing with calcium, avoiding obesity, quitting smoking and limiting alcohol, and reducing the amount of food full fat are all tips for fighting prostate cancer. Dr. Li Zhaokang recommends that men aged 50-70 years should have a PSA test every two years. Once lesions are detected, they can be treated as early as possible.

Update/download the AM730 mobile APP now to experience the update function

<img alt="New member points reward program Open the App and enter the member area to experience the upgrade function." height="1920" src="https://cdn.am730.com.hk/s3fs-public/styles/ad_mobile_size/public/2024-10/am730_AMJETSO_event%20card_1080x1920_3.jpg?itok=SJYsWc-r” width=”1080″/>